NO984432L - FremgangsmÕte for behandling av migrenesmerte - Google Patents

FremgangsmÕte for behandling av migrenesmerte

Info

Publication number
NO984432L
NO984432L NO984432A NO984432A NO984432L NO 984432 L NO984432 L NO 984432L NO 984432 A NO984432 A NO 984432A NO 984432 A NO984432 A NO 984432A NO 984432 L NO984432 L NO 984432L
Authority
NO
Norway
Prior art keywords
procedure
treatment
migraine pain
migraine
pain
Prior art date
Application number
NO984432A
Other languages
English (en)
Other versions
NO984432D0 (no
Inventor
Harlan E Shannon
Daniel E Womer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO984432D0 publication Critical patent/NO984432D0/no
Publication of NO984432L publication Critical patent/NO984432L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO984432A 1996-03-25 1998-09-23 FremgangsmÕte for behandling av migrenesmerte NO984432L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1412796P 1996-03-25 1996-03-25
PCT/US1997/004471 WO1997035582A1 (en) 1996-03-25 1997-03-24 Method for treating migraine pain

Publications (2)

Publication Number Publication Date
NO984432D0 NO984432D0 (no) 1998-09-23
NO984432L true NO984432L (no) 1998-11-24

Family

ID=21763694

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984432A NO984432L (no) 1996-03-25 1998-09-23 FremgangsmÕte for behandling av migrenesmerte

Country Status (17)

Country Link
US (1) US5929070A (no)
EP (1) EP0932407A4 (no)
JP (1) JP2001508759A (no)
KR (1) KR20000004966A (no)
CN (1) CN1106196C (no)
AU (1) AU721290B2 (no)
BR (1) BR9708145A (no)
CA (1) CA2250186A1 (no)
CZ (1) CZ298398A3 (no)
EA (1) EA000769B1 (no)
IL (1) IL126063A (no)
NO (1) NO984432L (no)
NZ (1) NZ332037A (no)
PL (1) PL329221A1 (no)
UA (1) UA44838C2 (no)
WO (1) WO1997035582A1 (no)
YU (1) YU42098A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL329217A1 (en) * 1996-03-25 1999-03-15 Lilly Co Eli Pain relieving method
PL187926B1 (pl) * 1996-03-25 2004-11-30 Lilly Co Eli Kompozycja farmaceutyczna do leczenia bólu
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
NZ540208A (en) * 2002-11-26 2007-09-28 Alexza Pharmaceuticals Inc Treatment of headache with antipsychotics delivered by inhalation
MXPA05005611A (es) 2002-11-26 2005-07-27 Alexza Pharmaceuticals Inc Uso de loxapina y amoxapina para la fabricacion de un medicamento para el tratamiento del dolor.
CA2526478A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
AU2004322756B2 (en) 2004-08-12 2011-04-14 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
ES2303462B1 (es) * 2004-09-06 2009-06-05 Shasun Chemicals And Drugs Limited Nuevo procedimiento para la preparacion de una forma polimorfica i de olanzapina farmaceuticamente pura.
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
US10736842B2 (en) 2014-06-25 2020-08-11 Synergia Bio Sciences Private Limited Pharmaceutical oil-in-water nano-emulsion
US11400048B2 (en) 2014-06-25 2022-08-02 Synergia Bio Sciences Private Limited Pharmaceutical oil-in-water nano-emulsion
MX2020007997A (es) 2018-02-02 2020-12-03 Alexza Pharmaceuticals Inc Dispositivo electrico de aerosol de condensacion.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
WO1993000094A2 (en) * 1991-06-21 1993-01-07 Smithkline Beecham Plc Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine
DK206591D0 (da) * 1991-12-23 1991-12-23 Lundbeck & Co As H Behandling af psykoser
DE69329887T2 (de) * 1992-05-29 2001-05-23 Eli Lilly And Co., Ltd. Thienobenzodiazepinderivate zur Behandlung von Störungen des Zentralnervensystems
JPH09510216A (ja) * 1994-03-11 1997-10-14 イーライ・リリー・アンド・カンパニー ５−ｈｔ▲下２ｂ▼受容体に関連する病態を治療するための方法
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
AU2584597A (en) 1997-10-17
NO984432D0 (no) 1998-09-23
KR20000004966A (ko) 2000-01-25
NZ332037A (en) 2001-01-26
AU721290B2 (en) 2000-06-29
CN1106196C (zh) 2003-04-23
IL126063A (en) 2002-04-21
EP0932407A1 (en) 1999-08-04
PL329221A1 (en) 1999-03-15
EP0932407A4 (en) 2002-04-24
UA44838C2 (uk) 2002-03-15
EA000769B1 (ru) 2000-04-24
JP2001508759A (ja) 2001-07-03
CA2250186A1 (en) 1997-10-02
US5929070A (en) 1999-07-27
BR9708145A (pt) 1999-07-27
WO1997035582A1 (en) 1997-10-02
CZ298398A3 (cs) 1999-06-16
EA199800864A1 (ru) 1999-02-25
CN1219876A (zh) 1999-06-16
IL126063A0 (en) 1999-05-09
YU42098A (sh) 1999-09-27

Similar Documents

Publication Publication Date Title
NO984431D0 (no) FremgangsmÕte for behandling av smerte
NO991381L (no) Kombinasjonsterapi for behandling av psykoser
NO991955L (no) FremgangsmÕte for behandling av hydrokarboner
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
NO20003042L (no) FremgangsmÕte for profylaktisk behandling av mastitt
NO991459L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
NO984432D0 (no) FremgangsmÕte for behandling av migrenesmerte
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
ATE347372T1 (de) Vakzine zur behandlung von mycosen
NO984446D0 (no) FremgangsmÕte for behandling av smerte
ATE226071T1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz
NO994258L (no) Anvendelse av levobupivakain for behandling av ansiktsmigrene
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO982582D0 (no) FremgangsmÕte for behandling av smerte
NO982562D0 (no) Sammensetning for behandling av smerte
NO984189D0 (no) Fremgangsmåte for behandling av bipolar forstyrrelse
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO991158L (no) FremgangsmÕte for behandling av amyotrofisk lateralsklerose
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
NO20010390D0 (no) Behandling av angstsykdommer
NO952411D0 (no) Midler for behandling av metaboliske bensykdommer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application